UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features

World journal of surgical oncology, 2012-08, Vol.10 (1), p.174-174, Article 174

2012

Volltextzugriff (PDF)

MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix

World journal of surgical oncology, 2014-11, Vol.12 (1), p.334-334

2014

Volltextzugriff (PDF)

Investigating the potential genetic association between RANBP9 polymorphisms and the risk of schizophrenia

Molecular medicine reports, 2015-04, Vol.11 (4), p.2975-2980

2015

Volltextzugriff (PDF)

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial

The lancet oncology, 2020-12, Vol.21 (12), p.1653-1660

2020

Volltextzugriff (PDF)

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Cancer discovery, 2020-08, Vol.10 (8), p.1194-1209

2020

Volltextzugriff (PDF)

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

International journal of hematology, 2021, Vol.113 (1), p.81-91

2021

Volltextzugriff (PDF)

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9614-9623

2008

Volltextzugriff (PDF)

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

Thoracic cancer, 2018-07, Vol.9 (7), p.856-864

2018

Volltextzugriff (PDF)

Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas

The Journal of pathology, 2021-01, Vol.253 (1), p.94-105

2021

Volltextzugriff (PDF)

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016

Cancer Research and Treatment, 2019, 51(2), , pp.417-430

2019

Volltextzugriff (PDF)

Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells

Cancer research (Chicago, Ill.), 2019-04, Vol.79 (7), p.1369-1382

2019

Volltextzugriff (PDF)

Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People

Cancers, 2022-05, Vol.14 (10), p.2521

2022

Volltextzugriff (PDF)

An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations

BMC cancer, 2021-07, Vol.21 (1), p.802-802, Article 802

2021

Volltextzugriff (PDF)

Predictors of the Response to Gefitinib in Refractory Non–Small Cell Lung Cancer

Clinical cancer research, 2005-03, Vol.11 (6), p.2244-2251

2005

Volltextzugriff (PDF)

Bacteria-Derived Extracellular Vesicles in Urine as a Novel Biomarker for Gastric Cancer: Integration of Liquid Biopsy and Metagenome Analysis

Cancers, 2021-09, Vol.13 (18), p.4687

2021

Volltextzugriff (PDF)

Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.6778-6787

2023

Volltextzugriff (PDF)

Prognostication of anaplastic astrocytoma patients: application of contrast leakage information of dynamic susceptibility contrast-enhanced MRI and dynamic contrast-enhanced MRI

European radiology, 2020-04, Vol.30 (4), p.2171-2181

2020

Volltextzugriff (PDF)

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.2572-2579

2023

Volltextzugriff (PDF)

Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

Clinical cancer research, 2008-11, Vol.14 (22), p.7397-7404

2008

Volltextzugriff (PDF)

Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial

Journal of clinical oncology, 2020-02, Vol.38 (5), p.434-443

2020

Volltextzugriff (PDF)

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

Gynecologic oncology, 2011-01, Vol.120 (1), p.56-62

2011

Volltextzugriff (PDF)

Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer

Oncotarget, 2016-11, Vol.7 (46), p.76274-76290

2016

Volltextzugriff (PDF)

Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study

The lancet oncology, 2019-10, Vol.20 (10), p.1454-1466

2019

Volltextzugriff (PDF)

Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

International journal of hematology, 2019-01, Vol.109 (1), p.79-90

2019

Volltextzugriff (PDF)

Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly through suppression of the Akt pathway

International journal of oncology, 2014-10, Vol.45 (4), p.1629-1637

2014

Volltextzugriff (PDF)

1 – 25 von 376

Suche als RSS-Feed

Aktive Filter

KollektionNature Journals

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(350)

Publikationsform

Artikel
(376)

Sprache

Englisch
(373)
Koreanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(23)
Molecular Medicine Reports
(18)
Cancer Research And Treatment
(17)
Annals Of Hematology
(16)
Cancer Research And Treatment/cancer Research And Treatment
(15)
Cancers
(15)
Oncotarget
(14)
Anticancer Research
(13)
Annals Of Surgical Oncology
(10)
Clinical Cancer Research
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features

MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix

Investigating the potential genetic association between RANBP9 polymorphisms and the risk of schizophrenia

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016

Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells

Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People

An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations

Predictors of the Response to Gefitinib in Refractory Non–Small Cell Lung Cancer

Bacteria-Derived Extracellular Vesicles in Urine as a Novel Biomarker for Gastric Cancer: Integration of Liquid Biopsy and Metagenome Analysis

Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma

Prognostication of anaplastic astrocytoma patients: application of contrast leakage information of dynamic susceptibility contrast-enhanced MRI and dynamic contrast-enhanced MRI

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation

Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer

Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study

Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly through suppression of the Akt pathway

Aktive Filter

Suchergebnisse filtern